NMR study of mutations of glycine-52 of the catalytic domain of diphtheria toxin
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 150, 72-79
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Protein carriers of conjugate vaccines: Characteristics, development and clinical trialsHuman Vaccines & Immunotherapeutics, 2013
- Comparative effects of carrier proteins on vaccine-induced immune responseVaccine, 2011
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programsExpert Review of Vaccines, 2009
- Effect of Vaccination with Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays as Predictors of ProtectionInfection and Immunity, 2002
- Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infantsThe Journal of Pediatrics, 1992
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197Nucleic Acids Research, 1984
- Immunogenic Correlation between Cross-Reacting Material (CRM197) Produced by a Mutant of Corynebacterium diphtheriae and Diphtheria ToxoidThe Journal of Infectious Diseases, 1980
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.Journal of Experimental Medicine, 1980
- CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINSJournal of Experimental Medicine, 1929